Urine Omics Predicting IO Therapy Responses in mRCC Patients
NCT04712305 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2022-01-20
Summary
The study aims to identify urinary metabolite and protein markers that can predict anti-tumor efficacy and adverse events in subjects receiving IO-based therapies for metastatic renal cell carcinoma.
Conditions
- Metastatic Renal Cell Carcinoma
Interventions
- OTHER
-
No intervention required
No intervention required
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-04
- Primary Completion
- 2025-12-31
- Completion
- 2027-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Tumor-Derived Extracellular Vesicles for Noninvasive Molecular Classification of Kidney Cancer
NCT07243067 ·Status: NOT_YET_RECRUITING
-
Optimal Methods of Disease Progression and Survival Analysis in Children and Adults Patients With Adrenocortical Cancer (ACC)
NCT04358107 ·Status: ACTIVE_NOT_RECRUITING
-
Clinical Relevance of NGS Analysis for High-purity CTC From Cancer Patients With Disruptive Gene Mutation(s)
NCT03002350 ·Status: UNKNOWN
-
Development of Urologic Registry for Personalized Medicine in Patients With Urological Malignancy by Analyzing Circulating Tumor DNA
NCT04197414 ·Status: RECRUITING
-
Performance Evaluation of a Urine-based Methylation Assay for Urothelial Carcinoma
NCT06912672 ·Status: NOT_YET_RECRUITING
-
Myeloid Derived Suppressor Cells Clinical Assay in Finding Kidney Cancer
NCT02664883 ·Status: ACTIVE_NOT_RECRUITING
-
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
NCT02090530 ·Status: RECRUITING
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Renal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450448 ·Status: COMPLETED
-
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
NCT04623502 ·Status: RECRUITING ·Phase: NA
-
Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer
NCT04883827 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Kidney Cancer
NCT01642095 ·Status: WITHDRAWN
-
KidneyCare Cohort Study (KCC-S)
NCT06898632 ·Status: COMPLETED
-
Urine Methylation Markers in UTUC
NCT06805630 ·Status: RECRUITING ·Phase: NA
-
Data Collection, Clinical Care and Interventions in CCR, NCI
NCT00923065 ·Status: ENROLLING_BY_INVITATION
-
Urine Proteome of Surgical Patients and Healthy Volunteers
NCT01538823 ·Status: COMPLETED
-
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
NCT04669860 ·Status: SUSPENDED
-
Utilization of the OncoCEE™ Platform to Evaluate Selected Biomarker Alterations in CTCs Isolated From Patients With MBC
NCT02436772 ·Status: COMPLETED
-
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
NCT05251883 ·Status: RECRUITING
-
Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma
NCT01374672 ·Status: COMPLETED
-
A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse)
NCT00001938 ·Status: COMPLETED
-
microRNA Expression in Renal Cell Carcinoma
NCT00743054 ·Status: COMPLETED
-
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
NCT00364715 ·Status: COMPLETED
-
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
NCT01173445 ·Status: COMPLETED
-
Study of Kidney Tumors in Younger Patients
NCT00898365 ·Status: COMPLETED
-
Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results
NCT04060485 ·Status: UNKNOWN